Published in Clin Exp Dermatol on November 01, 1986
U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol (2002) 4.92
UK guidelines for the management of cutaneous melanoma. Br J Plast Surg (2002) 3.51
Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol (2010) 2.22
British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol (2010) 1.95
Systemic complement activation in psoriasis vulgaris. Clin Exp Dermatol (1996) 1.94
Tanning with ultraviolet A sunbeds. BMJ (1990) 1.93
Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84
Oculoplastic reconstruction following Mohs surgery. Eye (Lond) (1998) 1.54
Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol (1997) 1.52
Juvenile plantar dermatosis: a new entity?. Clin Exp Dermatol (1976) 1.51
Naevoid hypertrichosis--report of a patient with multiple lesions. Clin Exp Dermatol (1989) 1.50
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent. BMJ (2003) 1.46
Basal cell carcinoma: are early appointments justifiable? Br J Dermatol (2000) 1.41
Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. Br J Dermatol (1994) 1.39
The suitability of SunCheck patches and Tanscan cards for monitoring the sunburning effectiveness of sunlight. Br J Dermatol (1993) 1.38
Health and the ozone layer. BMJ (1988) 1.37
UVA-induced melanocytic lesions. Br J Dermatol (1987) 1.35
Advances in the management of congenital and infantile cataract. Eye (Lond) (2007) 1.31
Guidelines for the management of lichen sclerosus. Br J Dermatol (2002) 1.31
Chemical and microbiological comparisons of inhibitors derived thermally from nitrite with an iron thionitrosyl (Roussin black salt). J Gen Microbiol (1974) 1.23
Porocarcinoma arising in a broad clonal seborrhoeic keratosis. Clin Exp Dermatol (2008) 1.23
Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma. J Clin Pathol (1977) 1.20
Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg (2010) 1.16
Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J Exp Med (1989) 1.16
A recurrent mutation in the loricrin gene underlies the ichthyotic variant of Vohwinkel syndrome. Clin Exp Dermatol (2002) 1.15
Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol (1984) 1.14
Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol (1988) 1.09
Assessment of prognosis in patients with malignant melanoma. Lancet (1972) 1.05
Lichen nitidus presenting as palmoplantar hyperkeratosis and nail dystrophy. Clin Exp Dermatol (1993) 1.05
Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol (1994) 1.04
Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol (1990) 1.04
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04
Clinical accuracy of the diagnosis of cutaneous malignant melanoma. Br J Dermatol (1998) 1.03
Acute disseminated epidermal necrosis due to omeprazole. Lancet (1992) 1.02
Pyoderma gangrenosum associated with Behçet's syndrome--response to thalidomide. Clin Exp Dermatol (1988) 1.01
The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. Aliment Pharmacol Ther (1998) 1.01
Extensive bullous lichen sclerosus with scarring alopecia. Clin Exp Dermatol (2008) 1.00
Evaluation of nurse prescribing in a dermatology unit. Br J Dermatol (1995) 1.00
An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol (2004) 1.00
Cell-mediated immunity in patients with malignant melanoma. Br J Dermatol (1972) 0.99
Subcutaneous sarcoidosis mimicking breast carcinoma. Br J Dermatol (2002) 0.98
Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions. Br J Dermatol (1981) 0.98
Sensitization to tumour-associated antigens in human breast carcinoma. Int J Cancer (1974) 0.97
Dermatomyositis and lymphoma. Arch Dermatol (1988) 0.97
Seven-point checklist for melanoma. Clin Exp Dermatol (1991) 0.96
Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma. Acta Paediatr (1999) 0.95
Epidemiology of scabies: the new epidemic. Lancet (1991) 0.95
Increased collagen-linked fluorescence in skin of young patients with type I diabetes mellitus. Diabetes Care (1990) 0.94
The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3. Hum Genet (2000) 0.93
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study. Br J Cancer (2001) 0.93
Eczéma craquelé resulting from acute oedema: a report of seven cases. Br J Dermatol (2001) 0.92
Facial harmony. Am J Orthod (1971) 0.92
An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol (1998) 0.92
Fibrillin-rich microfibrils of the extracellular matrix: ultrastructure and assembly. Micron (2001) 0.91
Calcium determines the supramolecular organization of fibrillin-rich microfibrils. J Cell Biol (1998) 0.90
Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro. J Invest Dermatol (1988) 0.90
Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients. Psychooncology (1997) 0.90
Quantitation of dendritic cells in normal and abnormal human epidermis using monoclonal antibodies directed against Ia and HTA antigens. J Invest Dermatol (1983) 0.90
Severe reaction to diphosphonate: implications for treatment of Paget's disease. BMJ (1988) 0.89
Leukocyte migration inhibition by cancer patients' sera. Int J Cancer (1976) 0.89
Arborizing telangiectasia with gastrointestinal involvement. Clin Exp Dermatol (1987) 0.89
The incidence of hydroxyethyl starch-associated pruritus. Br J Dermatol (2001) 0.89
Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010. Br J Dermatol (2010) 0.88
The prescription of isotretinoin to women: is every precaution taken? Br J Dermatol (1998) 0.88
Serum anti-tumour antibodies and auto-antibodies in vitiligo. Br J Dermatol (1975) 0.88
The distribution and quantification of the Langerhans cell in normal human epidermis. Clin Exp Dermatol (1986) 0.88
Cutaneous reactions to aluminium in vaccines: an avoidable problem. Lancet (1988) 0.87
Tioconazole nail solution--an open study of its efficacy in onychomycosis. Clin Exp Dermatol (1985) 0.87
Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol (1996) 0.87
Asymmetrical tanning in hemiplegia. Practitioner (1984) 0.87
Plantar malignant melanoma in a white Caucasian population. Br J Dermatol (1993) 0.87
Letter: Formalin-fixed tumour cells in the leukocyte migration test. Lancet (1973) 0.86
Bambuterol: effective in nocturnal asthma. Respir Med (1993) 0.86
An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol (1997) 0.86
Air quality in the vicinity of urban roads. Sci Total Environ (1990) 0.86
Can you COPE with CONSORT? Br J Dermatol (2000) 0.85
Crossed-leg callosities. Acta Derm Venereol (1985) 0.85
An assessment of the diagnostic value of the monoclonal antibodies Leu 8, OKT9, OKT10 and Ki67 in cutaneous lymphocytic infiltrates. Br J Dermatol (1986) 0.85
Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy (2000) 0.85
Lupus erythematosus in association with finger-clubbing. Br J Dermatol (1973) 0.85
Pustular psoriasis in association with renal amyloidosis. Br J Dermatol (1974) 0.85
The effect of treatment with 13-cis-retinoic acid on the metabolic burst of peripheral blood neutrophils from patients with acne. Br J Dermatol (1991) 0.85
An acantholytic dyskeratotic epidermal naevus with other features of Darier's disease on the same side of the body. Br J Dermatol (1992) 0.84
The prognostic value of blood glucose and glycosylated haemoglobin estimation in patients with stroke. Postgrad Med J (1986) 0.84
Lowered ultraviolet minimal erythema dose in hemiplegia. Postgrad Med J (1985) 0.84
Streptococcal necrotizing fasciitis and the dermatologist. Br J Dermatol (1999) 0.84
Lichen planus associated with captopril: a further disorder demonstrating the 'tin-tack' sign. Br J Dermatol (1989) 0.84
Natural-killer-cell activity in atopic dermatitis. Clin Allergy (1984) 0.83
The relationship between immunological parameters and response to therapy in resistant oral candidosis. Br J Dermatol (1978) 0.83
Bell's Palsy associated with hypothyroidism. Br J Clin Pract (1985) 0.83
Formalinized tumour cells in the leucocyte migration inhibition test. Clin Exp Immunol (1975) 0.83
Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol (1992) 0.82
Basal cell carcinoma in a skin graft recipient site. Practitioner (1984) 0.82
Bowel-associated dermatitis-arthritis syndrome associated with ileo-anal pouch anastomosis, and treatment with mycophenolate mofetil. Br J Dermatol (2003) 0.82
Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol (1997) 0.82
Porokeratosis in association with lymphoedema. Clin Exp Dermatol (2005) 0.81